Efficacy of Immune Checkpoint Inhibitors and Their Combinations in Previously Treated Advanced Hepatocellular Carcinoma: A Systematic Review of Clinical Trials

被引：0
|
作者：
Aiman, Wajeeha [1 ]
Ali, Muhammad Ashar [2 ]
Ali, Mukarram Jamat [3 ]
Rayad, Mohammad Nabil [1 ]
Mirza, Noreen [1 ]
Shaaban, Hamid [1 ]
Guron, Gunwant [1 ]
Maroules, Michael [2 ]
机构：
[1] St Michaels Hosp, Newark, NJ USA
[2] St Marys & St Clares Hosp, New York Med Coll, Denville, NJ USA
[3] Howard Univ Hosp, Washington, DC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1619
引用
收藏
页码：S1215 / S1216
页数：2
相关论文
共 50 条
  • [1] Efficacy of Immune Checkpoint Inhibitors in Combination With TKIs in Hepatocellular Carcinoma: A Systematic Review of Clinical Trials
    Ali, Mukarram Jamat
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1067 - S1068
  • [2] Immune checkpoint inhibitors in hepatocellular carcinoma: A review of current clinical trials
    Gamboa, Adriana C.
    Kooby, David A.
    Maithel, Shishir K.
    Gamblin, T. Clark
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (01) : 63 - 70
  • [3] Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Dyhl-Polk, Anne
    Mikkelsen, Marta Kramer
    Ladekarl, Morten
    Nielsen, Dorte Lisbet
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [4] The evolution of immune checkpoint inhibitor combinations in advanced hepatocellular carcinoma-A systematic review
    Meyers, Brandon M.
    Knox, Jennifer J.
    Liu, David M.
    McLeod, Deanna
    Ramjeesingh, Ravi
    Tam, Vincent C.
    Lim, Howard J.
    [J]. CANCER TREATMENT REVIEWS, 2023, 118
  • [5] Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma
    Kalasekar, Sharanya Maanasi
    Garrido-Laguna, Ignacio
    Evason, Kimberley Jane
    [J]. HEPATOLOGY, 2021, 73 (06) : 2591 - 2593
  • [6] Unleashing the efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma: factors, strategies, and ongoing trials
    Yu, Jiahui
    Li, Mengnan
    Ren, Boxu
    Cheng, Le
    Wang, Xiaoxiao
    Ma, Zhaowu
    Yong, Wei Peng
    Chen, Xiaoguang
    Wang, Lingzhi
    Goh, Boon Cher
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
    Guven, Deniz Can
    Stephen, Bettzy
    Sahin, Taha Koray
    Cakir, Ibrahim Yahya
    Erul, Enes
    Aksoy, Sercan
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
  • [8] Impact of metformin on clinical outcomes in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
    Khalil, Lana
    Kang, Sandra
    McCook-Veal, Ashley
    Draper, Amber
    Diab, Maria
    Shaib, Walid Labib
    Alese, Olatunji B.
    El-Rayes, Bassel F.
    Akce, Mehmet
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Immune checkpoint inhibitors in cutaneous squamous cell carcinoma: A systematic review of clinical trials
    Anwar, Muhammad Yasir
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Dhanesar, Gurneel
    Zafar, Maha
    Omar, Zainab
    Afzal, Fatima
    Guron, Gunwant K.
    Shaaban, Hamid Salim
    Maroules, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis
    Di Nunno, Vincenzo
    De Luca, Emmanuele
    Buttigliero, Consuelo
    Tucci, Marcello
    Vignani, Francesca
    Gatto, Lidia
    Zichi, Clizia
    Ardizzoni, Andrea
    Di Maio, Massimo
    Massari, Francesco
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 124 - 132
12345